Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Core-genome Single-nucleotide Polymorphism Analysis of Streptococcus pyogenes M1 Clone from Korea During the Pre-COVID-19 Era

  • Takashi Takahashi (Laboratory of Infectious Diseases, Graduate School of Infection Control Sciences and Omura Satoshi Memorial Institute, Kitasato University) ;
  • Takahiro Maeda (Laboratory of Infectious Diseases, Graduate School of Infection Control Sciences and Omura Satoshi Memorial Institute, Kitasato University) ;
  • Hyoshim Shin (Department of Laboratory Medicine, Gyeongsang National University College of Medicine) ;
  • Sunjoo Kim (Department of Laboratory Medicine, Gyeongsang National University College of Medicine)
  • Received : 2025.04.01
  • Accepted : 2025.08.11
  • Published : 2025.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

This study was supported by the Ministry of Trade, Industry, and Energy of Korea (grant No. RS 2024-00403563). The funders had no role in the study design, data collection and interpretation, or decision to submit the manuscript for publication.

References

  1. Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis 2019;19:1209–18. https://doi.org/10.1016/S1473-3099(19)30446-3
  2. Demczuk W, Martin I, Domingo FR, MacDonald D, Mulvey MR. Identification of Streptococcus pyogenes M1UK clone in Canada. Lancet Infect Dis 2019;19:1284–5. https://doi.org/10.1016/S1473-3099(19)30622-X
  3. Li Y, Nanduri SA, Van Beneden CA, Beall BW. M1UK lineage in invasive group A streptococcus isolates from the USA. Lancet Infect Dis 2020;20:538–9. https://doi.org/10.1016/S1473-3099(20)30279-6
  4. Rümke LW, de Gier B, Vestjens SMT, van der Ende A, van Sorge NM, Vlaminckx BJM, et al. Dominance of M1UK clade among Dutch M1 Streptococcus pyogenes. Lancet Infect Dis 2020;20:539–40. https://doi.org/10.1016/S1473-3099(20)30278-4
  5. Friães A, Mamede R, Santos B, Melo-Cristino J, Ramirez M, Portuguese Group for the Study of Streptococcal Infections. Characteristics of Streptococcus pyogenes causing invasive infections among adults in Portugal, 2016-2019: pre-COVID-19 expansion of the M1UK sublineage. J Microbiol Immunol Infect 2025;58:333–9. https://doi.org/10.1016/j.jmii.2025.01.009
  6. Yu D, Zheng Y, Chen Y, You Y, Yang Y. Streptococcus pyogenes M1UK presence in China in 2018. J Glob Antimicrob Resist 2025;42:175–6. https://doi.org/10.1016/j.jgar.2025.02.017
  7. Kim JW and Lee KJ. Development of a single-nucleotide polymorphism genotyping assay for the rapid detection of vancomycin-intermediate resistance in Staphylococcus aureus epidemic lineage ST5. Ann Lab Med 2023;43:355–63. https://doi.org/10.3343/alm.2023.43.4.355
  8. Shin H, Takahashi T, Lee S, Choi EH, Maeda T, Fukushima Y, et al. Comparing genomic characteristics of Streptococcus pyogenes associated with invasiveness over a 20-year period in Korea. Ann Lab Med 2022;42:438–46. https://doi.org/10.3343/alm.2022.42.4.438
  9. Tamura K. Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+C-content biases. Mol Biol Evol 1992;9:678–87.
  10. Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol 2021;38:3022–7. https://doi.org/10.1093/molbev/msab120
  11. Mavroidi A, Katsiaflaka A, Petinaki E, Froukala E, Papadopoulos D, Vrioni G, et al. M1UK Streptococcus pyogenes causing community-acquired pneumonia, pleural empyema and streptococcal toxic shock syndrome. J Glob Antimicrob Resist 2024;37:185-9. https://doi.org/10.1016/j.jgar.2024.03.016